Mission Statement:
CreoMed is dedicated to the discovery, development and distribution of new technologies and products for the global nutraceutical, medical, and pharmaceutical markets.
Vision:
CreoMed’s seeks to lead the nutraceutical and cosmeceutical industry focusing on premier dietary supplements, nutraceutical, cosmeceutical, and pharmaceutical products. The company is positioning itself to compete globally by establishing proper dosing and optimal treatment monitoring for all of its products based on sound science and clinical testing; “quantifying the qualitative.” Through the development of a cost-efficient system of distribution and the building of a strong brand, the company anticipates significant acceptance of its products in the market.
Our MNSA patent process is unique and trend-setting.
CreoMed’s product lines, based on compounds with centuries of use in man and formulated by industry experts are designed to exceed the highest standards globally.
|
Featured on MDLinx.com
The following article 'Preliminary Observations of a Novel Topical Oil with Analgesic Properties for Treatment of Acute and Chronic Pain Syndromes' in Pain Practice was featured on our MDLinx.com.
-----------------------------------------
Pergolizzi JV et al. – Essential oxygen oil (OxyRub from CreoMed Inc., Naples, FL, U.S.A.) is a novel topical analgesic currently commercially available in Europe and now available in the U.S.A. It represents an important alternative to other treatments (nonsteroidal anti–inflammatory drugs, acetaminophen, menthol, camphor) for managing mild to moderate acute and chronic pain. Several clinical trials of this oil will be reviewed...Based on studies completed, essential oxygen oil has shown itself to be safe, has demonstrated positive analgesic effects for the treatment of acute and chronic pain, and has improved oxygen content in the skin as well as other dermatological parameters.
Click here to read the entire article |
|
